Day One Biopharmaceuticals Inc (DAWN): Next-Year EPS Estimate 78.57%
As of 2026-05-07, Day One Biopharmaceuticals Inc (DAWN) has a next-year EPS growth estimate of 78.57%.
On 2026-05-04, analyst consensus for DAWN's next-year EPS growth shifted from 101.20% to 78.57% — a negative change of 22.63 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 59.62%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 78.57%
- EPS growth this year
- 59.62%
- EPS next quarter (est)
- -$0.11
- Last price
- $21.53
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 78.57% | 59.62% | -$0.11 | $21.53 |
| 2026-05-06 | 78.57% | 59.62% | -$0.11 | $21.53 |
| 2026-05-05 | 78.57% | 59.62% | -$0.11 | $21.53 |
| 2026-05-04 | 78.57% | 59.62% | -$0.11 | $21.53 |
| 2026-05-03 | 101.20% | 60.10% | -$0.11 | $21.53 |
| 2026-04-30 | 81.75% | 8.65% | -$0.42 | $21.53 |
| 2026-04-29 | 81.75% | 8.65% | -$0.42 | $21.53 |
| 2026-04-28 | 81.75% | 8.65% | -$0.42 | $21.53 |
| 2026-04-27 | 81.75% | 8.65% | -$0.42 | $21.53 |
| 2026-04-26 | 75.18% | 11.09% | -$0.38 | $21.53 |
| 2026-04-24 | 81.17% | 24.30% | -$0.28 | $21.53 |
| 2026-04-23 | 81.17% | 24.30% | -$0.28 | $21.53 |
| 2026-04-22 | 76.31% | 25.02% | -$0.28 | $21.53 |
| 2026-04-21 | 76.31% | 25.02% | -$0.28 | $21.49 |
| 2026-04-20 | 76.31% | 25.02% | -$0.28 | $21.48 |
| 2026-04-19 | 76.31% | 25.02% | -$0.28 | $21.47 |
| 2026-04-16 | 76.31% | 25.02% | -$0.28 | $21.45 |
| 2026-04-15 | 76.31% | 25.02% | -$0.28 | $21.47 |
| 2026-04-14 | 76.31% | 25.02% | -$0.28 | $21.46 |
| 2026-04-13 | 76.31% | 25.02% | -$0.28 | $21.49 |
| 2026-04-12 | 76.31% | 25.02% | -$0.28 | $21.47 |
| 2026-04-10 | 76.31% | 25.02% | -$0.28 | $21.47 |
| 2026-04-09 | 76.31% | 25.02% | -$0.28 | $21.48 |
| 2026-04-08 | 76.31% | N/A | -$0.28 | $21.44 |
| 2026-04-07 | 76.31% | N/A | -$0.28 | $21.46 |
| 2026-04-06 | 76.31% | N/A | -$0.28 | $21.46 |
| 2026-04-05 | 76.31% | N/A | -$0.28 | $21.45 |
| 2026-04-03 | 76.31% | N/A | -$0.28 | $21.46 |
| 2026-04-02 | 76.31% | N/A | -$0.28 | $21.46 |
| 2026-04-01 | 76.31% | N/A | -$0.28 | $21.46 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Day One Biopharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-05-07, Day One Biopharmaceuticals Inc (DAWN) has a next-year EPS growth estimate of 78.57%, based on analyst consensus.
When was the latest EPS estimate revision for DAWN?▾
The most recent revision occurred on 2026-05-04, when analysts adjusted the next-year EPS growth estimate from 101.20% to 78.57%.
What sector and industry does Day One Biopharmaceuticals Inc belong to?▾
Day One Biopharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. DAWN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Day One Biopharmaceuticals Inc (DAWN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports